We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has announced a shortage of albuterol metered-dose inhalers containing both chlorofluorocarbons (CFCs) and the nonozone-depleting propellant hydrofluoroalkane (HFA).